WEST HILLS, CALIFORNIA, May 24, 2021 / PRNewswire / – A research article published on BMJ Open found that more than 2/3 of US adults and 95% of US children are currently not consuming enough omega-3s in their daily diet to meet their nutritional needs Cover US dietary guidelines.

This cross-sectional study, conducted by Pharmavite, the manufacturer of vitamins and nutritional supplements from Nature Made, analyzed U.S. population data from the National Health and Nutrition Examination Survey (NHANES) 2011-2012 to determine the serum (blood) biomarker reference ranges of circulating long-chain (LC) omega-3 fatty acids (EPA, DPA and DHA). The 2011-2012 NHANES survey was the most recent survey to provide this information. The study looked at the proportion of the US population who had an omega-3 nutrient gap, with serum omega-3 concentrations below the recommendations of the US dietary guidelines and lower levels associated with reducing cardiovascular risk.

“Low serum levels confirm that omega-3 fatty acid intake is inadequate in most Americans, especially young children, and it shows that more work is needed to educate the public about the important roles played by EPA, and DPA To enlighten DHA in helping human health. “Said Dr. Susan Mitmesser, VP, Science & Technology, Pharmavit. “Healthy habits developed early in development inform and pave a healthy path later in life. Therefore, it is important that young children have access to foods rich in essential nutrients, including omega, in addition to sleep and physical activity -3 fatty acids. “

Other important results of the study are:

  • Despite extensive research pointing to the benefits of omega-3 fatty acids, particularly EPA and DHA, the regular dietary intake of omega-3 fatty acids in the US population remains low through all stages of life. Low serum concentrations of EPA, DHA and the sum of all omega-3 fatty acids were observed across all life stages.
  • Children 2 to 5 years of age, adult males, and Mexican-American / Hispanic and non-Hispanic black individuals were counted as having particularly low serum EPA and / or DHA levels based on life stages, gender, and demographic factors.

Supportive but inconclusive research suggests that consuming EPA and DHA omega-3 fatty acids may reduce the risk of coronary artery disease. However, there is a growing body of research to suggest that omega-3 fatty acids may play an even greater role than previously thought in areas of human health and wellbeing, particularly in terms of supporting a healthy mood.

Earlier this year, a study conducted by Pharmavite and published in the Journal of Affective Disorders Reports first examined the relationship between depression and levels of omega-3 fatty acids (EPA and DHA) in the circulatory system (based on analyzes by NHANES 2011-2012). Analysis of the data found that adults with higher levels of omega-3 fatty acids were correlated with a lower risk of depression, and adults with a higher EPA were correlated with a lower risk of the effects of depression on daily life.

Rachel A. Murphy, Prasad Devarshi, Shauna Ekimura, Keri Marshall and Dr. Susan H. Mitmesser. Long chain omega-3 fatty acid serum concentrations over life phases in The United States: An analysis by NHANES 2011-2012. BMJ Open. Volume 11, Issue 5.
https://bmjopen.bmj.com/content/11/5/e043301

Rachel A. Murphy, Prasad Devarshi, Shauna Ekimura, Keri Marshall and Dr. Susan H. Mitmesser. Serum long-chain omega-3 fatty acids and depression in adults The United States: An analysis by NHANES 2011-2012. Journal of Affective Disorders Reports. Volume 4, April 2021100089.
https://www.sciencedirect.com/science/article/pii/S2666915321000160

About Pharmavite LLC
Pharmavite is a pioneer in the health and wellness industry, gaining the trust of consumers, health professionals and retailers by developing innovative vitamin and supplement solutions that are science backed and strict manufacturing practices. With its brands Nature Made®, EQUELLE®, MegaFood® and Nurish by Nature Made®, Pharmavite aims to help people lead a healthier and more vital life. Based in California, Pharmavite is a subsidiary of Otsuka Pharmaceutical Co., Ltd. Visit www.pharmavite.com and follow us on LinkedIn for the latest news and information about Pharmavite and its brands.

SOURCE Pharmavite LLC

similar links

www.pharmavite.com

LEAVE A REPLY

Please enter your comment!
Please enter your name here